Encompass Health Corporation
EHC
$99.25
-$0.42-0.42%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.37B | 5.22B | 5.07B | 4.96B | 4.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.37B | 5.22B | 5.07B | 4.96B | 4.80B |
| Cost of Revenue | 3.14B | 3.06B | 2.98B | 2.91B | 2.82B |
| Gross Profit | 2.23B | 2.16B | 2.10B | 2.05B | 1.98B |
| SG&A Expenses | 266.50M | 264.40M | 260.00M | 265.00M | 258.00M |
| Depreciation & Amortization | 299.60M | 291.70M | 280.60M | 280.30M | 273.90M |
| Other Operating Expenses | 802.60M | 781.00M | 762.30M | 745.10M | 719.10M |
| Total Operating Expenses | 4.51B | 4.39B | 4.28B | 4.20B | 4.07B |
| Operating Income | 864.50M | 822.10M | 792.40M | 760.70M | 731.80M |
| Income Before Tax | 749.60M | 713.00M | 674.20M | 639.40M | 607.20M |
| Income Tax Expenses | 150.20M | 149.80M | 144.10M | 138.60M | 132.20M |
| Earnings from Continuing Operations | 599.40 | 563.20 | 530.10 | 500.80 | 475.00 |
| Earnings from Discontinued Operations | -2.80M | -11.70M | -12.30M | -12.30M | -12.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -140.90M | -129.10M | -118.30M | -111.70M | -111.00M |
| Net Income | 455.70M | 422.40M | 399.50M | 376.80M | 352.00M |
| EBIT | 864.50M | 822.10M | 792.40M | 760.70M | 731.80M |
| EBITDA | 1.16B | 1.11B | 1.07B | 1.04B | 1.01B |
| EPS Basic | 4.53 | 4.20 | 3.98 | 3.76 | 3.51 |
| Normalized Basic EPS | 3.28 | 3.17 | 3.04 | 2.89 | 2.70 |
| EPS Diluted | 4.46 | 4.14 | 3.92 | 3.71 | 3.48 |
| Normalized Diluted EPS | 3.21 | 3.11 | 2.98 | 2.83 | 2.65 |
| Average Basic Shares Outstanding | 399.60M | 399.10M | 398.70M | 398.30M | 397.90M |
| Average Diluted Shares Outstanding | 408.60M | 407.80M | 407.10M | 406.20M | 404.90M |
| Dividend Per Share | 0.64 | 0.62 | 0.60 | 0.60 | 0.60 |
| Payout Ratio | 13.78% | 14.37% | 15.19% | 16.11% | 17.16% |
